Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma THW abrdn quarterly earnings reflect managements optimistic longterm outlook for global healthcare investment opportunities CDZIP Cadiz posts wider than expected Q3 2025 loss shares remain flat following quarterly earnings release